Company page
Abivax Sa
Abivax SA is a public company listed under the ticker ABVXP on the UK market. The company has a market capitalization of approximately £7.88 billion. Abivax focuses on developing innovative therapies for inflammatory diseases and viral infections.
- Ticker
- ABVX:EURONEXT
- Asset type
- Stock
- Market cap
- $7.88B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- EURONEXT
- Currency
- EUR